Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SOLV
Solventum Corporation (SOLV) Debt to equity
Solventum Corporation's debt to equity at the end of the quarter to 30 June 2026 was 1.1×, up 0.1× from fiscal 2025 (1.0×). That is above the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 1.0× | (63.16%) |
| FY2024 | 2.7× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 1.1× | 3.51% |
| Mar 2026 | 1.1× | 6.70% |
| Dec 2025 | 1.0× | (3.21%) |
| Sep 2025 | 1.0× | (51.94%) |
| 11 more quarters | Free account |
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| ALGN Align Technology, Inc. compare | 0.0× |
| WST West Pharmaceutical Services, Inc. compare | 0.1× |
| ALC Alcon compare | 0.2× |
| RGEN Repligen Corporation compare | 0.3× |
| COO The Cooper Companies, Inc. compare | 0.3× |
| ATR AptarGroup, Inc. compare | 0.5× |
| AVTR Avantor, Inc. compare | 0.7× |
| SOLV Solventum Corporation | 1.1× |
| BAX Baxter International Inc. compare | 1.5× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement